Medtech Giant Ottobock Plans IPO, Eyes €4.2B Valuation

Ottobock, a German prosthetic manufacturer, is going public on the Frankfurt Stock Exchange with an anticipated valuation of €4.2 billion. The company plans to offer 12.24 million shares at €66 each, aiming to generate around €807 million in capital. Ottobock, the world's leading manufacturer of prosthetics, is preparing for its initial public offering on the Frankfurt Stock Exchange. The German medtech company anticipates a valuation of €4.2 billion. Reuters reports that Ottobock plans to offer 12.24 million shares at a price of €66 per share. This offering is projected to.